Navigation Links
Allon Therapeutics' CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
Date:3/7/2011

's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.

Forward-Looking Statements:

Statements contained herein, other than those which are strictly statements of historical fact may include forward-looking information. Such statements will typically contain words such as "believes", "may", "plans", "will", "estimate", "continue", "anticipates", "intends", "expects", and similar expressions. While forward-looking statements represent management's outlook based on assumptions that management believes are reasonable, forward-looking statements by their nature are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by them. Such factors include, among others, the inherent uncertainty involved in scientific research and drug development, Allon's early stage of development, lack of product revenues, its additional capital requirements, the risks associated with successful completion of clinical trials and the long lead-times and high costs associated with obtaining regulatory approval to market any product which Allon may eventually develop. Other risk factors include the limited protections afforded by intellectual property rights, rapid technology and product obsolescence in a highly competitive environment and Allon's dependence on collaborative partners and contract research organizations. These factors can be reviewed in Allon's public filings at www.SEDAR.com and should be considered carefully. Readers are cautioned not to place undue reliance on such forward-looking statements and Allon disclaims any obligation to update or announce changes in any such factors except in its periodic filings.

'/>"/>

SOURCE Allon Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
2. Allon Therapeutics to Present Live, Online at RetailInvestorConferences.com on March 3rd
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015  Student-athletes at community ... benefit from a recently established partnership between ImPACT ... California . The partnership enables member institutions ... distribute ImPACT ® concussion baseline and post-injury ... majority of community colleges in California ...
(Date:7/6/2015)...  Array BioPharma Inc. (Nasdaq: ARRY ) ... Ron Squarer , will present at the Cantor ... The public is welcome to participate in the ... website. Event: Cantor Fitzgerald 2015 Healthcare ConferencePresenter:Ron Squarer, Chief ... Webcast: www.arraybiopharma.com About Array BioPharma Array BioPharma ...
(Date:7/6/2015)... ST. PAUL, Minn. , July 6, 2015 /PRNewswire/ ... manufacturer of devices that use neuroblocking technology to treat ... termination of the underwriting agreement and cancellation of its ... a price to the public of $0.87 per unit. ... book-running manager and Craig-Hallum Capital Group was acting as ...
Breaking Medicine Technology:California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 2California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 3EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants 2
... EF Johnson Technologies, Inc. (Nasdaq: EFJI ), a ... results for the quarter ended September 30, 2009. Revenues ... was $1.6 million, or $(0.06) per diluted share, for the ... pleased with our orders and contract awards, the third quarter ...
... Inc. (NYSE: ZMH ; SIX: ZMH) announced today that ... unsecured notes in an underwritten public offering consisting of $500.0 ... 5.75% notes due 2039. The 10-year notes were priced to ... 30-year notes were priced at 135 basis points above their ...
Cached Medicine Technology:EF Johnson Technologies Announces Third Quarter Results 2EF Johnson Technologies Announces Third Quarter Results 3EF Johnson Technologies Announces Third Quarter Results 4EF Johnson Technologies Announces Third Quarter Results 5EF Johnson Technologies Announces Third Quarter Results 6EF Johnson Technologies Announces Third Quarter Results 7EF Johnson Technologies Announces Third Quarter Results 8Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes 2
(Date:7/6/2015)... ... 06, 2015 , ... For over twenty years, Doctors on Liens ... Throughout the company’s history the goal has been to be a comprehensive network of ... And while Doctors on Liens has certainly achieved that goal, the addition of ...
(Date:7/6/2015)... ... 07, 2015 , ... Currently, mobile testing is one the ... in the molecular diagnostic technologies, wide availability of immunosuppressive drugs and bioterrorism threats ... genetic engineering also open lucrative opportunities for the market players. , However, there ...
(Date:7/6/2015)... Yorba Linda, CA (PRWEB) , ... July 06, ... ... human biology into the pre-clinical stages of drug discovery. iPSCs are generated from ... potential to differentiate into any cell type in the human body. , ...
(Date:7/6/2015)... ... ... Respected southern California personal injury attorney Fernando D. Vargas has been honored ... has sharp legal skills as well as a superior commitment to client service. , ... a Top 10 Award from The National Academy of Personal Injury Attorneys (NAOPIA). , ...
(Date:7/6/2015)... ... July 06, 2015 , ... PristineHydro ( http://www.pristinewaterfilters.com ) ... chemicals and impurities; it also properly mineralizes the water with electrolyte salts.  Common ... These harmful contaminants are a byproduct of how the water is treated chemically.  ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2
... older adults, already shown to improve health, can also cut ... the University of Washington. The study appears in the February ... depression affects about 3 million older adults in the United ... health-care expenses, mostly due to an increased use of medical, ...
... Regional,Foodbank, which distributes millions of pounds of food to ... more than 30,000 pounds of meat,to help feed local ... America tour, an initiative led by celebrity cook,Paula Deen., ... servings of meat to the,nation,s hungry families, including those ...
... Feb. 6 Worrell Inc., a full-service,product design ... the Montreal and San Diego offices of Gad ... prowess with the,engineering proficiencies of Gad Shaanan Design., ... Worrell Inc.,-- International Kai Worrell. "We know how ...
... Presented at 15th Conference on ... Opportunistic Infections (CROI), BOSTON, Feb. 6 Schering-Plough ... of a Phase II clinical study,showed vicriviroc, its investigational ... weeks of therapy in treatment-,experienced HIV-infected patients, when administered ...
... (February 6, 2008)Perhaps the only positive spin one can put ... Other than that, the news is bad. It is nearly ... of their lives, and the limited treatment options have changed ... are determined to find new ways treat this poorly understood ...
... for Health Solutions study outlines plan to help,primary ... WASHINGTON, Feb. 6 Primary care physicians,should ... diseases,and be compensated accordingly for their enhanced role ... Deloitte Center for Health Solutions,( http://www.deloitte.com/centerforhealthsolutions ) concludes., ...
Cached Medicine News:Health News:Team treatment for depression cuts medical costs 2Health News:Team treatment for depression cuts medical costs 3Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour to L.A. 2Health News:Celebrity Cook Paula Deen and Husband Michael Groover Bring Smithfield Foods' Helping Hungry Homes(TM) Tour to L.A. 3Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 2Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 3Health News:Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients 4Health News:Gene plays 'Jekyll and Hyde' in brain cancer 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 3Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 2Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 3
Immunodiffusion tests are used for the detecion of precipitating antibodies (primarily of the IgG and IgA classes) against antigens of C. albicans. The presence of precipitating antibodies indicates ...
The best value and features offered in a complete EMR and Practice Management Solution...
... Department has worked extensively with practicing urologists ... and exam templates for the most commonly ... the most flexible electronic medical record systems ... to take the templates we have provided ...
... CellaVision DM96 is an Automated Digital Cell ... pre-classification/characterization, display, storage and transmission of White ... 96 stained peripheral blood smears can be ... from 30 60 per hour depending ...
Medicine Products: